Case Report
Ibrutinib-Associated Cardiac Tamponade with Concurrent Antiplatelet Therapy
Table 1
Laboratory studies on admission and prior to admission.
| | Laboratory studies | Outside hospital 5/8/2019 | Admission 5/13/2019 | Reference ranges |
| | White blood count (WBC) | 16.9 | 16.3 | 4.0–11.0 × 109/L | | Hemoglobin | 11.6 | 10.5 | 13.7–17.0 g/dL | | Platelet count | 137 | 204 | 150–400 × 109/L | | Creatinine | 1.1 | 2.43 | 0.7–1.2 mg/dL | | Alanine transaminase (ALT) | 9 | 93 | 16–61 U/L | | Aspartate transaminase (AST) | 21 | 59 | 15–37 U/L | | Alkaline phosphatase | 43 | 123 | 45–117 U/L | | Prothrombin time (PT) | 10.5 | 15 | 12.3–14.6 sec | | Partial thromboplastin time (PTT) | 27.7 | 29 | 23–36 sec | | International normalized ratio (INR) | 1.0 | 1.2 | 0.8–1.2 |
|
|
